LGLuke Gammon

Luke Gammon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luke Gammon has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Adrian Biddle

    Blizard Institute, Barts & The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom

    1 shared publication
  • Alice Scemama

    Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London

    1 shared publication
  • Gehad Youssef

    Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London

    1 shared publication
  • Hannah Cottom

    Department of Cellular Pathology, Barts Health NHS Trust

    1 shared publication
  • Ian C Mackenzie

    Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London

    1 shared publication
  • Kim Piper

    Department of Cellular Pathology, Barts Health NHS Trust

    1 shared publication

Latest Publications

  • Open Access

    Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learning

    by Gehad Youssef, Luke Gammon, Leah Ambler, Sophia Lunetto, Alice Scemama, Hannah Cottom, Kim Piper, Ian C Mackenzie, Michael P Philpott, Adrian Biddle

    Cancer stem cells (CSCs) undergo epithelial-mesenchymal transition (EMT) to drive metastatic dissemination in experimental cancer models. However, tumour cells undergoing EMT have not been observed disseminating into the tissue surrounding human tumour specimens, leaving the relevance to human cancer uncertain. We have previously identified both EpCAM and CD24 as CSC markers that, alongside the mesenchymal marker Vimentin, identify EMT CSCs in human oral cancer cell lines. This afforded the opportunity to investigate whether the combination of these three markers can identify disseminating EMT CSCs in actual human tumours. Examining disseminating tumour cells in over 12,000 imaging fields from 74 human oral tumours, we see a significant enrichment of EpCAM, CD24 and Vimentin co-stained cells disseminating beyond the tumour body in metastatic specimens. Through training an artificial neural network, these predict metastasis with high accuracy (cross-validated accuracy of 87–89%). In this study, we have observed single disseminating EMT CSCs in human oral cancer specimens, and these are highly predictive of metastatic disease.